The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
According to AbbVie's latest financial reports the company's current revenue (TTM) is $58.05 B. In 2021 the company made a revenue of $56.19 B an increase over the years 2020 revenue that were of $45.80 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $58.05 B | 3.3% |
2021 | $56.19 B | 22.69% |
2020 | $45.80 B | 37.69% |
2019 | $33.26 B | 1.57% |
2018 | $32.75 B | 16.08% |
2017 | $28.21 B | 10.06% |
2016 | $25.63 B | 12.16% |
2015 | $22.85 B | 14.52% |
2014 | $19.96 B | 6.23% |
2013 | $18.79 B | 2.23% |
2012 | $18.37 B | 5.36% |
2011 | $17.44 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $100.33 B | 72.82% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $28.54 B | -50.84% | ๐บ๐ธ USA |
![]() Amgen AMGN | $26.32 B | -54.66% | ๐บ๐ธ USA |
![]() Biogen BIIB | $10.17 B | -82.48% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $27.28 B | -53.01% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $46.15 B | -20.49% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $44.35 B | -23.61% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | $38.94 B | -32.92% | ๐ฌ๐ง UK |
![]() Neurocrine Biosciences
NBIX | $1.48 B | -97.44% | ๐บ๐ธ USA |